Showing results (451-460 of 504) with videos related to

Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2019
Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficienciesElena Blanco, Martín Pérez-Andrés, Sonia Arriba-Méndez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Blood Advances|September 27, 2018
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisJulie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical ReviewTheo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Haematologica|February 13, 2008
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disordersAndy C Rawstron, Alberto Orfao, Meral Beksac, et al.
Cancer Research|February 8, 2022
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed MiceAna Casado-García, Marta Isidro-Hernández, Ninad Oak, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 3, 2023
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future PerspectivesPeter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Hemasphere|June 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencingNatalia Buenache, Marta Lasa, Andrés Arroyo, et al.
Pageof 51